Sore Relief
Product Images NDC 69804-077

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sore Relief (NDC 69804-077). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ridge Properties Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage And Administration (Dosage And Administration)

This text provides directions for using a product to relieve pain. It advises testing the skin first and stopping use if any sensitivity occurs. The product should be applied in thick, even layers at intervals of 3-5 minutes until the desired level of pain relief is achieved. It also warns against using the product near the eyes.*

FDA Label Image

Inactive Ingredient Section (Inactive Ingredients Section)

FDA Label Image

Indications And Usage (Indications And Usage)

FDA Label Image

Keep Out Of Reach Of Children (Keep Out Of Reach Of Children)

This text seems to be a warning label for a product. It warns the user to keep the product away from children and mentions that it is for use around the eyes. In case of ingestion, medical help should be sought immediately or Poison Control should be called. Unfortunately, the text also contains a few non-English characters and is not fully understandable.*

FDA Label Image

Active Ingredients (Otc Active Ingredient)

FDA Label Image

Purpose (Purpose)

This text indicates that the purpose of a certain product is a topical anesthetic.*

FDA Label Image

Warnings Section (Warnings Section)

This is a warning to keep a product out of reach of children, and it should not be used around the eyes but only be used externally. If ingested, medical help should be immediately sought. It is also recommended to stop use and seek a doctor if the skin becomes irritated, if the condition worsens, if symptoms last longer than 7 days, or if symptoms clear up and then return. There is an unclear text at the end which could not be evaluated.*

FDA Label Image

Principal Display Panel (Principal Display Panel)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.